title: Pathogenic implications of iron accumulation in multiple sclerosis.
abstract: Iron, an essential element used for a multitude of biochemical reactions, abnormally accumulates in the CNS of patients with multiple sclerosis (MS). The mechanisms of abnormal iron deposition in MS are not fully understood, nor do we know whether these deposits have adverse consequences, that is, contribute to pathogenesis. With some exceptions, excess levels of iron are represented concomitantly in multiple deep gray matter structures often with bilateral representation, whereas in white matter, pathological iron deposits are usually located at sites of inflammation that are associated with veins. These distinct spatial patterns suggest disparate mechanisms of iron accumulation between these regions. Iron has been postulated to promote disease activity in MS by various means: (i) iron can amplify the activated state of microglia resulting in the increased production of proinflammatory mediators; (ii) excess intracellular iron deposits could promote mitochondria dysfunction; and (iii) improperly managed iron could catalyze the production of damaging reactive oxygen species (ROS). The pathological consequences of abnormal iron deposits may be dependent on the affected brain region and/or accumulation process. Here, we review putative mechanisms of enhanced iron uptake in MS and address the likely roles of iron in the pathogenesis of this disease.
authors: Department of Molecular & Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.
authors: Rachel
authors: R
authors: Williams
authors: Cassandra L
authors: CL
authors: Buchheit
authors: Nancy E J
authors: NE
authors: Berman
authors: Steven M
authors: SM
authors: LeVine
mesh_terms: D000818:Animals; D001808:Blood Vessels / Q000378:metabolism; D001923:Brain Chemistry / Q000502:physiology; D004195:Disease Models, Animal; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000378:metabolism; D018698:Glutamic Acid / Q000502:physiology; D006801:Humans; D007501:Iron / Q000378:metabolism*; D019266:Iron, Dietary / Q000378:metabolism; D008264:Macrophages / Q000378:metabolism; D008279:Magnetic Resonance Imaging; D017628:Microglia / Q000378:metabolism; D009103:Multiple Sclerosis / Q000378:metabolism*; D019636:Neurodegenerative Diseases / Q000378:metabolism / Q000503:physiopathology; D009498:Neurotoxins / Q000633:toxicity
chemical_list: D019266:Iron, Dietary; D009498:Neurotoxins; D018698:Glutamic Acid; D007501:Iron